Prediction of risk for symptomatic sialadenitis by post-therapeutic dual 131I scintigraphy in patients with differentiated thyroid cancer

Annals of Nuclear Medicine

Volumn 27, Issue 8, 2013, Pages 700-709

  Lee, Sang Mi ^a   Lee, Jeong Won ^b   Kim, Shin Young ^a   Han, Seon Wook ^a   Bae, Won Kyoung ^a  

^a Soonchunhyang University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Iodine 131; Post therapeutic scan; Salivary gland; Sialadenitis; Thyroid cancer

Indexed keywords

IODINE 131;

ADULT; AGED; ARTICLE; CANCER PATIENT; DIFFERENTIATED THYROID CANCER; FEMALE; HALF LIFE TIME; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; PAROTID GLAND; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SALIVARY GLAND FUNCTION; SALIVARY GLAND SCINTISCANNING; SALIVARY GLAND TO BACKGROUND UPTAKE RATIO; SIALOADENITIS; SUBMANDIBULAR GLAND; TREATMENT OUTCOME; WHOLE BODY SCINTISCANNING;

ADULT; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RISK ASSESSMENT; SALIVARY GLANDS; SIALADENITIS; THYROID NEOPLASMS; TIME FACTORS;

EID: 84886398595     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-013-0735-3     Document Type: Article

References (20)

1. - co-transport system. J Clin Invest. 1987;79:1310-3.
2. Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, et al. Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2008;35:1941-59.
3. Mandel SJ, Mandel L. Radioactive iodine and the salivary glands. Thyroid. 2003;13:265-71.
4. De La Vieja A, Dohan O, Levy O, Carrasco N. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol Rev. 2000;80:1083-105.
5. Wu SY, Brown T, Milne N, Eqbert R, Kabok A, Lyons KP, et al. Iodine 131 total body scan - extrathyroidal uptake of radioiodine. Semin Nucl Med. 1986;16:82-4.
6. Liu B, Kuang A, Huang R, Zhao Z, Zeng Y, Wang J, et al. Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial. J Nucl Med. 2010;51:618-23.
7. Liu B, Huang R, Kuang A, Zhao Z, Zeng Y, Wang J, et al. Iodine kinetics and dosimetry in the salivary glands during repeated courses of radioiodine therapy for thyroid cancer. Med Phys. 2011;38:5412-9.
8. Malpani BL, Samuel AM, Ray S. Quantification of salivary gland function in thyroid cancer patients treated with radioiodine. Int J Radiat Oncol Biol Phys. 1996;35:535-40.
9. Solans R, Bosch JA, Galofré P, Porta F, Roselló J, Selva-O'Callagan A, et al. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med. 2001;42:738-43.
10. Raza H, Khan AU, Hameed A, Khan A. Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy. Nucl Med Commun. 2006;27:495-9.
11. Caglar M, Tuncel M, Alpar R. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. Clin Nucl Med. 2002;27:767-71.
12. An YS, Yoon JK, Lee SJ, Song HS, Yoon SH, Jo KS. Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer. Ann Nucl Med. 2013;. doi: 10.1007/s12149-013-0697-5.
13. Nakada K, Ishibashi T, Takei T, Hirata K, Shinohara K, Katoh S, et al. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? J Nucl Med. 2005;46:261-6.
14. Allweiss P, Braunstein GD, Katz A, Waxman A. Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication. J Nucl Med. 1984;25:755-8.
15. Jeong SY, Kim HW, Lee SW, Ahn BC, Lee J. Salivary gland function five years after a radioiodine ablation in patients with differentiated thyroid cancer: direct comparison of pre and post-ablation scintigraphies and their relation to xerostomia symptoms. Thyroid. 2012;. doi: 10.1089/thy.2012.0106.
16. Stephens LC, Schultheiss TE, Price RE, Ang KK, Peters LJ. Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Cancer. 1991;67:1539-43.
17. Malpani BL, Samuel AM, Ray S. Differential kinetics of parotid and submandibular gland function as demonstrated by scintigraphic means and its possible implications. Nucl Med Commun. 1995;16:706-9.
18. 131I therapy in patients with well-differentiated thyroid cancer: preliminary report. Ann Nucl Med. 2011;25:439-46.
19. Chong A, Song H-C, Min J-J, Jeong S, Ha J-M, Kim J, et al. Improved detection of lung or bone metastases with an I-131 whole body scan on the 7th day after high-dose I-131 therapy in patients with thyroid cancer. Nucl Med Mol Imaging. 2010;44:273-81.
20. 131I whole-body scanning in patients with thyroid cancer. Clin Nucl Med. 2012;37:264-7.